125 related articles for article (PubMed ID: 28922150)
1. Synthesis, Radiosynthesis, and Preliminary in vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking Inhibitor (HPA-12) for Brain Applications.
Crivelli SM; Paulus A; Markus J; Bauwens M; Berkes D; De Vries HE; Mulder MT; Walter J; Mottaghy FM; Losen M; Martinez-Martinez P
J Alzheimers Dis; 2017; 60(3):783-794. PubMed ID: 28922150
[TBL] [Abstract][Full Text] [Related]
2. Ceramide analog [
Crivelli SM; van Kruining D; Luo Q; Stevens JAA; Giovagnoni C; Paulus A; Bauwens M; Berkes D; de Vries HE; Mulder MT; Walter J; Waelkens E; Derua R; Swinnen JV; Dehairs J; Mottaghy FM; Losen M; Bieberich E; Martinez-Martinez P
Sci Rep; 2020 Nov; 10(1):19354. PubMed ID: 33168861
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the CERT START domain with inhibitors provide insights into the mechanism of ceramide transfer.
Kudo N; Kumagai K; Matsubara R; Kobayashi S; Hanada K; Wakatsuki S; Kato R
J Mol Biol; 2010 Feb; 396(2):245-51. PubMed ID: 20036255
[TBL] [Abstract][Full Text] [Related]
4. Chemistry and Biology of HPAs: A Family of Ceramide Trafficking Inhibitors.
Berkeš D; Daïch A; Santos C; Ballereau S; Génisson Y
Chemistry; 2016 Dec; 22(49):17514-17525. PubMed ID: 27628428
[TBL] [Abstract][Full Text] [Related]
5. Expedient and practical synthesis of CERT-dependent ceramide trafficking inhibitor HPA-12 and its analogues.
Ďuriš A; Wiesenganger T; Moravčíková D; Baran P; Kožíšek J; Daïch A; Berkeš D
Org Lett; 2011 Apr; 13(7):1642-5. PubMed ID: 21351771
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
[TBL] [Abstract][Full Text] [Related]
7. Decreased ceramide transport protein (CERT) function alters sphingomyelin production following UVB irradiation.
Charruyer A; Bell SM; Kawano M; Douangpanya S; Yen TY; Macher BA; Kumagai K; Hanada K; Holleran WM; Uchida Y
J Biol Chem; 2008 Jun; 283(24):16682-92. PubMed ID: 18411267
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective synthesis and structure-activity relationship of novel ceramide trafficking inhibitors. (1R,3R)-N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide and its analogues.
Nakamura Y; Matsubara R; Kitagawa H; Kobayashi S; Kumagai K; Yasuda S; Hanada K
J Med Chem; 2003 Aug; 46(17):3688-95. PubMed ID: 12904073
[TBL] [Abstract][Full Text] [Related]
9. Natural Ligand-Mimetic and Nonmimetic Inhibitors of the Ceramide Transport Protein CERT.
Hanada K; Sakai S; Kumagai K
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216212
[TBL] [Abstract][Full Text] [Related]
10. CERT mediates intermembrane transfer of various molecular species of ceramides.
Kumagai K; Yasuda S; Okemoto K; Nishijima M; Kobayashi S; Hanada K
J Biol Chem; 2005 Feb; 280(8):6488-95. PubMed ID: 15596449
[TBL] [Abstract][Full Text] [Related]
11. A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis.
Yasuda S; Kitagawa H; Ueno M; Ishitani H; Fukasawa M; Nishijima M; Kobayashi S; Hanada K
J Biol Chem; 2001 Nov; 276(47):43994-4002. PubMed ID: 11546801
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
13. Interorganelle trafficking of ceramide is regulated by phosphorylation-dependent cooperativity between the PH and START domains of CERT.
Kumagai K; Kawano M; Shinkai-Ouchi F; Nishijima M; Hanada K
J Biol Chem; 2007 Jun; 282(24):17758-66. PubMed ID: 17442665
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
[TBL] [Abstract][Full Text] [Related]
15. 11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors.
Turolla EA; Matarrese M; Belloli S; Moresco RM; Simonelli P; Todde S; Fazio F; Magni F; Kienle MG; Leopoldo M; Berardi F; Colabufo NA; Lacivita E; Perrone R
J Med Chem; 2005 Nov; 48(22):7018-23. PubMed ID: 16250661
[TBL] [Abstract][Full Text] [Related]
16. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats.
Olberg DE; Bauer N; Andressen KW; Hjørnevik T; Cumming P; Levy FO; Klaveness J; Haraldsen I; Sutcliffe JL
Nucl Med Biol; 2016 Aug; 43(8):478-89. PubMed ID: 27236283
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis and ex vivo evaluation of [(18)F]-(S)-3-(6-(3-fluoropropoxy)benzo[d]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one for imaging MAO-B with PET.
Hicks JW; Sadovski O; Parkes J; Houle S; Hay BA; Carter RL; Wilson AA; Vasdev N
Bioorg Med Chem Lett; 2015 Jan; 25(2):288-91. PubMed ID: 25488845
[TBL] [Abstract][Full Text] [Related]
18. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
Sorger D; Scheunemann M; Grossmann U; Fischer S; Vercouille J; Hiller A; Wenzel B; Roghani A; Schliebs R; Brust P; Sabri O; Steinbach J
Nucl Med Biol; 2008 Feb; 35(2):185-95. PubMed ID: 18312828
[TBL] [Abstract][Full Text] [Related]
19. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
